SERPINE3 antibodies are immunodetection reagents designed to bind specifically to the SERPINE3 protein, a member of the serine protease inhibitor (serpin) family. These antibodies enable researchers to study SERPINE3's expression patterns, cellular localization, and interactions in experimental models. SERPINE3 is encoded by a gene conserved across vertebrates, with orthologs in zebrafish, mice, and humans .
Key characteristics of SERPINE3 include:
Structure: Contains a conserved reactive site loop (RSL) critical for protease inhibition .
Expression: Predominantly expressed in ocular tissues, including retinal Müller glia (zebrafish) and retinal pigment epithelium (mammals) .
Antibodies against SERPINE3 are typically generated using synthetic peptides or recombinant protein fragments. For example:
Immunogen design: A polyclonal antibody from Thermo Fisher (PA5-62514) uses a peptide sequence spanning residues VLELPYLGSA...KANLKGI, achieving 79% and 83% sequence identity with mouse and rat orthologs, respectively .
Epitope specificity: Antibodies targeting the C-terminal region (e.g., ab188155 from Abcam) are optimized for immunohistochemistry (IHC) in human tissues .
| Antibody Product | Vendor | Applications | Immunogen | Species Reactivity |
|---|---|---|---|---|
| PA5-62514 | Thermo Fisher | WB, ELISA, IHC | Synthetic peptide (N-terminal) | Human, Mouse, Rat |
| ab188155 | Abcam | IHC-P | Recombinant fragment (aa 300–C-terminus) | Human |
| Unspecified (Biocompare) | Multiple | ELISA, WB, IHC | Variable | Human, Mouse, Zebrafish |
SERPINE3 antibodies are employed in diverse experimental workflows:
Immunohistochemistry (IHC): Detects SERPINE3 in human colon tissue (ab188155) .
Western blot (WB): Validates protein expression in ocular extracts .
Ocular function: SERPINE3 knockout zebrafish exhibit retinal layering defects and altered eye morphology, highlighting its role in Müller glia-mediated retinal homeostasis .
Human polymorphisms: Two SERPINE3-linked SNPs correlate with vision-related traits, suggesting clinical relevance in eye disorders .
Conservation: SERPINE3’s inhibitory serpin structure (e.g., reactive site loop) is evolutionarily conserved, as confirmed by AlphaFold2 modeling .
SERPINE3 antibodies hold promise for:
Mechanistic studies: Elucidating SERPINE3’s role in retinal diseases like macular degeneration .
Biomarker development: Quantifying SERPINE3 in patient sera to assess ocular or cancer-related pathologies .
Therapeutic targeting: Blocking SERPINE3’s reactive site loop to modulate protease activity in disease models .
SERPINE3 (Serpin Family E Member 3) is a serine protease inhibitor belonging to the serpin superfamily. In humans, the canonical protein consists of 424 amino acid residues with a molecular mass of approximately 47 kDa . SERPINE3 functions as a secreted protein and is suspected to inhibit serine proteases through the characteristic serpin mechanism of forming stable complexes with target proteases, thereby preventing their interaction with substrates .
Research importance stems from SERPINE3's specific expression patterns and evolutionary conservation across species including mouse, rat, bovine, frog, zebrafish, chimpanzee, and chicken . Recent studies have particularly highlighted its essential role in vision-related functions, as evidenced by its independent loss in 18 lineages that do not primarily rely on vision for survival .
SERPINE3 antibodies serve multiple critical functions in research laboratories focused on protein detection and characterization. The primary applications include:
Enzyme-Linked Immunosorbent Assay (ELISA): For quantitative detection of SERPINE3 in biological samples
Western Blot (WB): For determining protein expression levels and molecular weight confirmation
Immunohistochemistry (IHC): For localizing SERPINE3 in tissue sections, particularly in paraffin-embedded samples
Additionally, immunofluorescence techniques have been employed to study SERPINE3's cellular and subcellular localization, especially in retinal tissues. In situ hybridization (ISH) and fluorescent in situ hybridization (FISH) are complementary techniques used to detect SERPINE3 mRNA expression patterns .
SERPINE3 follows the characteristic serpin fold structure common to the serpin superfamily. Three-dimensional structure prediction using AlphaFold2 has provided insights into SERPINE3's conformation, allowing comparison with homologous chains of existing crystal structures of related serpins .
Key functional domains include:
Signal peptide: Required for secretion (predicted using SignalP 5.0)
Reactive site loop (RSL): Critical for protease inhibition and specificity
β-sheet structure: Essential for the conformational change during protease inhibition
Post-translational modifications, particularly glycosylation, have been identified in SERPINE3, potentially affecting its function and stability . Up to two different isoforms have been reported for human SERPINE3, indicating potential functional diversity .
When searching literature databases or ordering antibodies, researchers should be aware of various nomenclature used for SERPINE3:
Serpin peptidase inhibitor, clade E member 3
Nexin-related serine protease inhibitor
Serpin E3
Related proteins in the serpin superfamily include:
SERPINE1 (PAI-1): Plasminogen activator inhibitor type 1
SERPINE2 (PN-1): Protease nexin-1
SerpinB3: While in a different clade, shares functional similarities as a serine protease inhibitor
Understanding these relationships is crucial for interpreting research findings and selecting appropriate experimental controls.
SERPINE3 exhibits tissue-specific expression patterns with particularly notable expression in the retinal pigment epithelium (RPE). According to eyeIntegration and plae database analyses, SERPINE3 shows distinct expression patterns in human and macaque retinas .
In zebrafish, in situ hybridization studies using probes spanning coding exons 3-8 have revealed serpine3 expression patterns in the eye, particularly after lens removal . The specific expression in RPE cells suggests a specialized function in maintaining retinal homeostasis and visual function.
Regulatory mechanisms controlling SERPINE3 expression remain incompletely understood, though evolutionary analysis suggests selection pressure may be relaxed in species that do not primarily rely on vision, as evidenced by RELAX analysis from the HyPhy suite (selection intensity parameter K<1) .
When investigating SERPINE3 function, researchers must consider several critical methodological aspects:
Genetic Models: CRISPR-mediated homologous recombination has been successfully employed to generate Serpine3-VenusGFP knockin mice, replacing exon 2 with a Venus reporter. This approach enables tracking of expression while disrupting protein function .
Functional Assays: Protease activity assays using fluorescently-labeled peptide substrates allow screening of SERPINE3 against major classes of proteases to identify specific targets .
Structural Analysis: For structure-function studies, researchers should consider both sequence analysis (using tools like DNASTAR Lasergene) and structural prediction (through AlphaFold2) to identify key functional regions and potential epitopes .
Tissue Analysis: When analyzing retinal phenotypes in model organisms, combinations of histological approaches (H&E staining), immunohistochemistry for tight junction markers (ZO-1), and photoreceptor-specific markers provide comprehensive assessment of structural integrity .
Developing highly specific antibodies against SERPINE3 presents several challenges:
Cross-reactivity with related serpins: The serpin superfamily contains structurally similar members that may share epitopes, potentially resulting in antibody cross-reactivity.
Distinguishing isoforms: With up to two reported isoforms of SERPINE3, targeting isoform-specific regions is essential for discriminating between variants .
Species specificity: While SERPINE3 is conserved across species, sequence variations may affect antibody recognition across different experimental models.
These challenges can be overcome through:
Epitope mapping: Identifying unique, exposed epitopes using software such as DNASTAR Lasergene and comparing with three-dimensional structures to select distinctive regions .
Peptide-based immunization: Using synthetic peptides corresponding to unique SERPINE3 regions for immunization, similar to approaches used for SerpinB3 antibody generation .
Extensive validation: Confirming antibody specificity through multiple techniques including ELISA against purified proteins, Western blotting, and immunohistochemistry with appropriate positive and negative controls .
The independent loss of SERPINE3 in 18 lineages that typically do not primarily rely on vision represents a striking example of convergent gene loss correlated with ecological adaptation . This pattern strongly predicts a vision-related function for SERPINE3.
Evolutionary analyses using RELAX from the HyPhy suite have been employed to test whether selection pressure is relaxed (K<1) or intensified (K>1) in species with unclear SERPINE3 loss status or in clades where many close relatives have lost the gene . These analyses provide insights into the timing and selective pressures driving SERPINE3 conservation or loss.
The convergent loss pattern also offers a powerful example of how comparative genomics can reveal functional insights about genes with previously unknown functions. This evolutionarily-informed approach to gene function prediction represents an innovative strategy that complements traditional experimental methods .
For optimal immunohistochemical detection of SERPINE3, researchers should follow these methodological guidelines:
Tissue Preparation:
Antibody Dilution and Incubation:
Detection Systems:
Controls:
Include positive controls (tissues known to express SERPINE3)
Include negative controls (omission of primary antibody)
Consider using knockout/knockdown tissues as specificity controls
Thorough validation of SERPINE3 antibodies is essential for generating reliable research data. A comprehensive validation strategy includes:
ELISA-based validation:
Western Blot validation:
Immunocytochemistry/Immunohistochemistry validation:
Knockout/knockdown controls:
For optimal Western blot detection of SERPINE3, researchers should follow this protocol:
Sample Preparation:
For recombinant protein: 4ng of purified protein is typically sufficient
For tissue/cell lysates: Extract in RIPA buffer with protease inhibitors
Denature samples in reducing buffer (containing β-mercaptoethanol)
Gel Electrophoresis:
Use 12% polyacrylamide gels for optimal resolution
Run at 100-120V until the dye front reaches the bottom
Transfer Conditions:
Blocking and Antibody Incubation:
Detection:
Troubleshooting:
If background is high, increase blocking time or detergent concentration
If signal is weak, extend primary antibody incubation or increase concentration
If multiple bands appear, verify with knockout controls or peptide competition
For comprehensive analysis of SERPINE3 function in retinal tissues, researchers should consider these specialized techniques:
In Situ Hybridization:
Design probes spanning multiple coding exons (e.g., exons 3-8)
Add restriction enzyme cut sites to primers for cloning
Clone into appropriate vectors (e.g., pCRII-topo)
Transcribe antisense probes with specific polymerases (e.g., SP6)
Use DIG-labeled NTP mix for detection
Fluorescent In Situ Hybridization (FISH):
Retinal Phenotype Analysis:
Functional Protease Assays:
Genetic Models:
SERPINE3 antibodies provide valuable tools for vision research and ophthalmological studies in several key applications:
RPE Cell Marker: As SERPINE3 shows specific expression in retinal pigment epithelium (RPE), antibodies against this protein serve as valuable markers for identifying and studying this critical cell population in both normal physiology and disease states .
Retinal Degeneration Models: SERPINE3 antibodies enable tracking of protein expression changes during retinal degeneration in various models. The Serpine3Gfp/Gfp mouse model has demonstrated that loss of SERPINE3 function leads to retinal degeneration, suggesting that antibody-based monitoring of SERPINE3 levels could serve as a biomarker for retinal health .
Therapeutic Target Validation: As retinal function appears dependent on proper SERPINE3 activity, antibodies that can modulate its function (activating or inhibiting) might serve as potential therapeutic agents or proof-of-concept tools for vision disorders.
Comparative Vision Studies: Given the evolutionary pattern of SERPINE3 loss in non-vision-dependent species, antibodies against this protein can facilitate comparative studies across species with varying visual capabilities .
The discovery that SERPINE3 is an RPE-specific protease inhibitor critical for retinal function suggests potential involvement in various retinal pathologies:
Age-related Macular Degeneration (AMD): As AMD involves dysfunction of the RPE, SERPINE3 antibodies can help investigate whether altered protease inhibition contributes to disease progression.
Inherited Retinal Degenerations: The retinal degeneration observed in Serpine3Gfp/Gfp mice suggests SERPINE3 dysfunction might contribute to certain inherited retinal diseases. Antibodies enable screening of patient samples for altered expression or localization .
Protease-Mediated Retinal Damage: SERPINE3 likely regulates specific proteases in the retinal microenvironment. Antibodies can help identify these target proteases through co-immunoprecipitation studies and investigate their dysregulation in disease states .
Diagnostic Applications: Developing sensitive ELISA assays using SERPINE3 antibodies might provide diagnostic tools for detecting retinal damage through measurement of released SERPINE3 in accessible fluids like aqueous humor.
Advanced research on SERPINE3 often requires integrating antibody-based approaches with complementary methodologies:
Antibody-Based Proteomics with Transcriptomics:
Structure-Function Studies:
Genetic Model Systems with Antibody Validation:
Evolutionary Analysis with Comparative Immunohistochemistry: